Advanced SearchSearch Tips
ACE-inhibitory Effect and Physicochemical Characteristics of Yogurt Beverage Fortified with Whey Protein Hydrolysates
facebook(new window)  Pirnt(new window) E-mail(new window) Excel Download
 Title & Authors
ACE-inhibitory Effect and Physicochemical Characteristics of Yogurt Beverage Fortified with Whey Protein Hydrolysates
Lim, Sung-Min; Lee, Na-Kyoung; Park, Keun-Kyu; Yoon, Yoh-Chang; Paik, Hyun-Dong;
  PDF(new window)
This study investigated the ACE-inhibitory effect of yogurt beverage fortified with hydrolysates as well as the suitability of hydrolysates as a nutraceutical additive to yogurt beverage. Three whey protein hydrolysates hydrolyzed by alcalase, protamex, and trypsin were each added to yogurt beverage at concentrations of 1.25, 2.5, and 5 mg/mL. Yogurt beverage fortified with 2.5 mg/mL of hydrolysates had 61-69% ACE-inhibitory activity, whereas yogurt beverage fortified with 5 mg/mL of hydrolysates showed 74% ACE-inhibitory activity. There were no significant differences in ACE-inhibitory activity between the alcalase or protamex hydrolysates during storage; however, trypsin hydrolysate exhibited significant differences. On the other hand, physicochemical characteristics such as pH (3.47-3.77), titratable acidity (0.81-0.84%), colority, viable cell count, and sensory qualities were not significantly different among the tested yogurt beverage samples during storage. These results showed that yogurt beverage fortified with whey protein hydrolysates maintained antihypertensive activity and underwent no unfavorable changes in physicochemical characteristics regardless of enzyme type.
angiotensin-converting enzyme;whey protein hydrolysate;yogurt beverage;
 Cited by
Effect of Flavourzyme®on Angiotensin-Converting Enzyme Inhibitory Peptides Formed in Skim Milk and Whey Protein Concentrate during Fermentation byLactobacillus helveticus, Journal of Food Science, 2016, 81, 1, M135  crossref(new windwow)
Physicochemical characterization of hydrolysates of whey protein concentrates for their use in nutritional beverages, Food Science and Biotechnology, 2015, 24, 4, 1335  crossref(new windwow)
Production of Angiotensin I Converting Enzyme Inhibitory (ACE-I) Peptides during Milk Fermentation and Their Role in Reducing Hypertension, Critical Reviews in Food Science and Nutrition, 2015, 00  crossref(new windwow)
Strategies of producing bioactive peptides from milk proteins to functionalize fermented milk products, Food Research International, 2014, 63, 71  crossref(new windwow)
Proteolytic and angiotensin-converting enzyme-inhibitory activities of selected probiotic bacteria, International Journal of Food Science & Technology, 2016, 51, 4, 865  crossref(new windwow)
AOAC (1995) Official methods of analysis. 16th ed, Association of Official Analytical Chemists, Washington, DC, USA.

Ariyoshi, Y. (1993) Angiotensin-converting enzyme inhibitor derived from food protein. Trends Food Sci. Technol. 4, 139-144. crossref(new window)

Campbell, D. J. (2003) The renin-angiotensin and the kallikrein-kinin systems. Int. J. Biochem. Cell Biotechnol. 35, 784-791. crossref(new window)

Christensen, J. E., Dudley, E. G., Pederson, J. A., and Steele, J. L. (1999) Peptidases and amino acid catabolism in lactic acid bacteria. Antonie van Leeuwenhoek 76, 217-246. crossref(new window)

Clare, A. and Swaisgood, H. E. (2000) Bioactive milk peptides: a prospectus. J. Dairy Sci. 86, 1187-1195.

Cushman, D. W. and Cheung, H. S. (1971) Spectrophotometric assay and properties of the angiotensin-converting enzyme of rabbit lung. Biochem. Pharmacol. 20, 1637-1648. crossref(new window)

Donkor, O. N., Henriksson, A., Vasiljevic, T., and Shah, N. P. (2007) Proteolytic activity of dairy lactic acid bacteria and probiotics as determinant of viability and in vitro angiotensin-converting enzyme inhibitory activity in fermented milk. Lait 87, 21-38. crossref(new window)

FitzGerald, R. J. and Murray, B. A. (2006) Bioactive peptides and lactic fermentations. Int. J. Dairy Technol. 59, 118-125. crossref(new window)

Fuglsang, A., Nilsson, D., and Nyborg, N. C. B. (2002) Cardiovascular effects of fermented milk containing angiotensin-converting enzyme inhibitors evaluated in permanently catheterized, spontaneously hypertensive rats. Appl. Environ. Microbiol. 68, 3566-3569. crossref(new window)

Fujita, H., Yamagami, T., and Ohshima, K. (2001) Effects of an ACE inhibitory agent, katsuobushi oligopeptide, in the spontaneously hypertensive rat and in borderline and mildly hypertensive subjects. Nutr. Res. 21, 1149-1158. crossref(new window)

Jang, A. and Lee, M. (2005) Purification and identification of angiotensin converting enzyme inhibitory peptides from beef hydrolysates. Meat Sci. 69, 653-661. crossref(new window)

Kim, S. B., Seo, I. S., Khan, M. A., Ki, K. S., Nam, M. S., and Kim, H. S. (2007) Separation of iron-binding protein from whey through enzymatic hydrolysis. Int. Dairy J. 17, 625-631. crossref(new window)

Korhonen, H. J. T. and Pihlanto, A. (2006) Bioactive peptides: Production and functionality. Int. Dairy J. 16, 945-960. crossref(new window)

Kunji, E. R. S., Mierau, I., Hagting, A., Poolman, B., and Konings, W. N. (1996) The proteolytic systems of lactic acid bacteria. Antonie van Leeuwenhoek 70, 187-221. crossref(new window)

Lopez-Fandino, R., Otte J., and van Camp, J. (2006) Physiological, chemical and technological aspects of milk-proteinderived peptides with antihypertensive and ACE-inhibitory activity. Int. Dairy J. 16, 1277-1293. crossref(new window)

Minervini, F., Algaron, F., Rizzello, C. G., Fox, P. F., Monnet, V., and Gobbetti, M. (2003) Angiotensin I-converting-enzyme-inhibitory and antibacterial peptides from Lactobacillus helveticus PR4 proteinase-hydrolyzed caseins of milk from six species. Appl. Environ. Microbiol. 69, 5297-5305. crossref(new window)

Nicholas, J. A. and Eric, C. R. (1996) Characterization of casein phosphopeptides prepared using alcalase. Enzyme Microb. Technol. 19, 202-207. crossref(new window)

Otte, J., Qvist, K. B., Pedersen, M., Vogensen, F. K., and Flambard, B. (2003) ACE-inhibitory activity of fermented milks: Effects of culture and protein concentration. Poster at the Conference Milk Proteins: Quality and Health Aspects., Wadahl, Norway, pp. 13-16.

Pihlanto-Leppala, A., Koskinen, P., Piilola, K., Tupasela, T., and Korhonen, H. (2000) Angiotensin I-converting enzyme inhibitory properties of whey protein digests: Concentration and characterization of active peptides. J. Dairy Res. 67, 53-64. crossref(new window)

SAS (1999) SAS/STAT Software for PC. SAS Institute Inc., Cary, NC, USA.

Seppo, L., Jauhiainen, T., Poussa, T., and Korpela, R. (2003) A fermented milk high in bioactive peptides has a blood pressure-lowering effect in hypertensive subjects. Am. J. Clin. Nutr. 77, 326-330.

Shah, N. P. (2000) Effect of milk-derived bioactives: An overview. Br. J. Nutr. 84, S3-S10.

Silvia, S. V. and Malcata, F. X. (2005) Caseins as source of bioactive peptides. Int. Dairy J. 15, 1-15. crossref(new window)

Sinha, R., Radha, C., Prakash, J., and Kaul, P. (2007) Whey protein hydrolysate: Functional properties, nutritional quality and utilization in beverage formulation. Food Chem. 101, 1484-1491. crossref(new window)

Van der Ven, C., Grupen, H., Bont, D. B. A., and Voragen, A. G. J. (2002) Optimization of the angiotensin converting enzyme inhibition by whey protein hydrolysates using response surface methodology. Int. Dairy J. 12, 813-820. crossref(new window)

Vermeirssen, V., Van Camp, J., Devos, L., and Verstraete, W. (2003) Release of angiotensin I converting enzyme (ACE) inhibitory activity during in vitro gastrointestinal digestion: From batch experiment to semicontinuous model. J. Agri. Food Chem. 51, 5680-5687. crossref(new window)

Yamamoto, N. (1997) Antihypertensive peptides derived from food proteins. Biopolymers 43, 129-134. crossref(new window)

Yamamoto, N., Akino, A., and Takano, T. (1994) Antihypertensive effect of the peptides derived from casein by an extracellular proteinase from Lactobacillus helveticus CP790. J. Dairy Sci. 77, 917-922. crossref(new window)

Yusuf, S., Lonn, E., Bosch, J., and Gerstein, H. (1999) Summary of randomised trials of angiotensin converting enzyme inhibitors. Clin. Exp. Hypertens. 21, 835-845. crossref(new window)